-
Featured Press Release
Aspira Women’s Health Inc. Announcement New York State Medicaid Now Considers OVA1 Medically Necessary as of April 1, 2021
Learn More -
Partner Event
Join our President and CEO, Valerie Palmieri, March 17 at 12PM for a congressional briefing via to address Advancing Health Outcomes for Women and Minorities.
Register Here -
Women's History Month
We celebrate you. The unstoppable force. The midnight warrior. The barrier breakers and rule-makers. The listening ears and messy hands. The ones that make the world and then make it better. You are who we work for every day.
Read More
Recent News
Choose a Category:
-
I have a pelvic mass. What should I do next?
Blog
What is a pelvic mass? A pelvic mass is a relatively common health issue and, in many cases, benign. These masses may form in the cervix, uterus, colon, intestine, bladder, or ovaries. Even if it is benign, they can cause problems depending on their size and placement relative to vital organs. It’s estimated that 20%…
-
Aspira Women’s Health Reports Fourth Quarter and Full Year 2020 Financial Results
Press Release
To read a PDF of this press release including balance sheets, please click here. Conference Call scheduled for today, March 25th at 4:30 p.m. ET AUSTIN, Texas — March 25, 2021 — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the fourth…
-
Aspira Women’s Health, Inc. Announces an Agreement for the Development and Commercialization of an Early-Detection Test for Identification of Ovarian Cancer
Press Release
For a PDF of this press release, please click here. AUSTIN, Texas — March 25th, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into an agreement with Dana-Farber Cancer Institute (DFCI), Brigham and Women’s Hospital, and Medical University Lodz to evaluate their novel microRNA (miRNA)…
-
10 Things I Want You to Know About Ovarian Cancer
By: Diane Powis, Ph.D.
Blog
By Diane Powis, Ph.D., Chief Spokeswoman at Aspira Women's Health In 2013, I was completely blindsided with a diagnosis of Stage III ovarian cancer. At that time, my prognosis was, at best, 5 years. I am still alive today because of incredible advances in gynecological oncology. However, staying alive has required regular surgeries and aggressive…
-
Aspira Women’s Health Inc. to Report Fourth Quarter and Full Year 2020 Financial Results
Press Release
For a pdf of this release please click here AUSTIN, Texas — March 18, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the fourth quarter and full year ended December 31st, 2020, on Thursday, March 25th, 2021, after the market close, followed…
Upcoming Events
-
April 30 – May 2, 2021
Virtual Exhibitor
American College of Obstetrics and Gynecologists Annual Meeting